SLC2A4 and sarcopenia: Our study contributes to this growing body of evidence by demonstrating that 4HR administration significantly alleviated sarcopenia in the masseter muscle of STZ-induced diabetic rats, likely through mechanisms involving enhancement of Glut4 expression and AMPK activation.